The Latin America, Middle East and Africa Interventional Oncology Market would witness market growth of 9.9% CAGR during the forecast period (2022-2028).
IO has proven to be especially effective in the treatment of pain in cancer patients, the huge majority of whom are unable to get enough relief from pain medications and radiotherapy. About 90% of cancer patients experience pain during their treatment, and nearly half of those with advanced cancer experience mild to severe pain. Minimally invasive IO procedures such as ablation, neurolysis, bone and vertebral augmentation are all effective palliative treatments for cancer pain. These treatments act on the tumour directly or indirectly, as in the case of regional anaesthesia from neurolysis, by limiting its growth and stabilising the lesion.
The United Arab Emirates (UAE) has one of the quicker economies in the world, which has resulted in a rise in noncommunicable diseases such as cancer. Although screening and early diagnosis efforts that seem to be far from objective coverage of the targeted respondents, the number of cases and death have been rising in the UAE over the years. The UAE's cancer control plan is being developed in accordance with WHO and EMRO guidelines, with specific objectives and goals in mind. The goals are to fight cancer, reduce its occurrence, control mortality, and enhance cancer patients' outcomes and quality of life. Improved public health education, early detection, prevention, fast diagnosis, continuity of care, treatment facilitation, workforce training, performance evaluation, and research are also priorities.
After cardiovascular illnesses and trauma, cancer is the third largest cause of mortality in the United Arab Emirates (UAE). The death ratio in the United Arab Emirates is 0.39, which is similar to other developed nations. Owing to the rise in the case of cancer, the regional interventional oncology market would augment in the forecast period.
The Brazil market dominated the LAMEA Interventional Oncology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $51.3 million by 2028. The Argentina market is experiencing a CAGR of 10.4% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 9.6% during (2022 - 2028).
Based on Cancer Type, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis, and Others. Based on Product Type, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Interventional Oncology Market is Predict to reach $2.9 Billion by 2028, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Terumo Corporation , Johnson & Johnson (Johnson & Johnson Services, Inc.), Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., and HealthTronics, Inc. (Altaris Capital Partners, LLC)
Scope of the Study
Market Segments Covered in the Report:
By Cancer Type
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Bone Metastasis
- Others
By Product Type
- Embolization Devices
- Ablation Devices
- Support Devices
By End User
- Hospitals
- Ambulatory Surgery Centers
- Research & Academic Institutes
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- Teleflex, Inc.
- Cook Medical, Inc. (Cook Group)
- Medtronic PLC
- Terumo Corporation
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Merit Medical Systems, Inc.
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Interventional Oncology Market, by Cancer Type
1.4.2 LAMEA Interventional Oncology Market, by Product Type
1.4.3 LAMEA Interventional Oncology Market, by End User
1.4.4 LAMEA Interventional Oncology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Interventional Oncology Market by Cancer Type
3.1 LAMEA Liver Cancer Market by Country
3.2 LAMEA Lung Cancer Market by Country
3.3 LAMEA Kidney Cancer Market by Country
3.4 LAMEA Breast Cancer Market by Country
3.5 LAMEA Prostate Cancer Market by Country
3.6 LAMEA Bone Metastasis Market by Country
3.7 LAMEA Others Market by Country
Chapter 4. LAMEA Interventional Oncology Market by Product Type
4.1 LAMEA Embolization Devices Market by Country
4.2 LAMEA Ablation Devices Market by Country
4.3 LAMEA Support Devices Market by Country
Chapter 5. LAMEA Interventional Oncology Market by End User
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Ambulatory Surgery Centers Market by Country
5.3 LAMEA Research & Academic Institutes Market by Country
Chapter 6. LAMEA Interventional Oncology Market by Country
6.1 Brazil Interventional Oncology Market
6.1.1 Brazil Interventional Oncology Market by Cancer Type
6.1.2 Brazil Interventional Oncology Market by Product Type
6.1.3 Brazil Interventional Oncology Market by End User
6.2 Argentina Interventional Oncology Market
6.2.1 Argentina Interventional Oncology Market by Cancer Type
6.2.2 Argentina Interventional Oncology Market by Product Type
6.2.3 Argentina Interventional Oncology Market by End User
6.3 UAE Interventional Oncology Market
6.3.1 UAE Interventional Oncology Market by Cancer Type
6.3.2 UAE Interventional Oncology Market by Product Type
6.3.3 UAE Interventional Oncology Market by End User
6.4 Saudi Arabia Interventional Oncology Market
6.4.1 Saudi Arabia Interventional Oncology Market by Cancer Type
6.4.2 Saudi Arabia Interventional Oncology Market by Product Type
6.4.3 Saudi Arabia Interventional Oncology Market by End User
6.5 South Africa Interventional Oncology Market
6.5.1 South Africa Interventional Oncology Market by Cancer Type
6.5.2 South Africa Interventional Oncology Market by Product Type
6.5.3 South Africa Interventional Oncology Market by End User
6.6 Nigeria Interventional Oncology Market
6.6.1 Nigeria Interventional Oncology Market by Cancer Type
6.6.2 Nigeria Interventional Oncology Market by Product Type
6.6.3 Nigeria Interventional Oncology Market by End User
6.7 Rest of LAMEA Interventional Oncology Market
6.7.1 Rest of LAMEA Interventional Oncology Market by Cancer Type
6.7.2 Rest of LAMEA Interventional Oncology Market by Product Type
6.7.3 Rest of LAMEA Interventional Oncology Market by End User
Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Regional Analysis
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations and Agreements:
7.5.5.2 Acquisitions and Mergers:
7.6 Johnson & Johnson (Johnson & Johnson Services, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Becton, Dickinson and Company
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 AngioDynamics, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.9 Merit Medical Systems, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.10. HealthTronics, Inc. (Altaris Capital Partners, LLC)
7.10.1 Company Overview
TABLE 1 LAMEA Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Liver Cancer Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Liver Cancer Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Kidney Cancer Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Kidney Cancer Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Bone Metastasis Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Bone Metastasis Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 20 LAMEA Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 21 LAMEA Embolization Devices Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Embolization Devices Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Ablation Devices Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Ablation Devices Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Support Devices Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Support Devices Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 28 LAMEA Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 29 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Interventional Oncology Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Interventional Oncology Market by Country, 2022 - 2028, USD Million
TABLE 37 Brazil Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 38 Brazil Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 39 Brazil Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 40 Brazil Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 41 Brazil Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 42 Brazil Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 43 Brazil Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 44 Brazil Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 45 Argentina Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 46 Argentina Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 47 Argentina Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 48 Argentina Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 49 Argentina Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 50 Argentina Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 51 Argentina Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 52 Argentina Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 53 UAE Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 54 UAE Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 55 UAE Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 56 UAE Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 57 UAE Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 58 UAE Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 59 UAE Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 60 UAE Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 63 Saudi Arabia Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 64 Saudi Arabia Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 65 Saudi Arabia Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 66 Saudi Arabia Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 67 Saudi Arabia Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 68 Saudi Arabia Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 69 South Africa Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 70 South Africa Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 71 South Africa Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 72 South Africa Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 73 South Africa Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 74 South Africa Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 75 South Africa Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 76 South Africa Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 77 Nigeria Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 78 Nigeria Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 79 Nigeria Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 80 Nigeria Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 81 Nigeria Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 82 Nigeria Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 83 Nigeria Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 84 Nigeria Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 85 Rest of LAMEA Interventional Oncology Market, 2018 - 2021, USD Million
TABLE 86 Rest of LAMEA Interventional Oncology Market, 2022 - 2028, USD Million
TABLE 87 Rest of LAMEA Interventional Oncology Market by Cancer Type, 2018 - 2021, USD Million
TABLE 88 Rest of LAMEA Interventional Oncology Market by Cancer Type, 2022 - 2028, USD Million
TABLE 89 Rest of LAMEA Interventional Oncology Market by Product Type, 2018 - 2021, USD Million
TABLE 90 Rest of LAMEA Interventional Oncology Market by Product Type, 2022 - 2028, USD Million
TABLE 91 Rest of LAMEA Interventional Oncology Market by End User, 2018 - 2021, USD Million
TABLE 92 Rest of LAMEA Interventional Oncology Market by End User, 2022 - 2028, USD Million
TABLE 93 key Information – Boston Scientific Corporation
TABLE 94 key Information – Teleflex, Inc.
TABLE 95 key Information – Cook Medical, Inc.
TABLE 96 Key Information – Medtronic PLC
TABLE 97 Key Information – Terumo Corporation
TABLE 98 Key information – Johnson & Johnson
TABLE 99 Key information – Becton, Dickinson and Company
TABLE 100 Key Information – AngioDynamics, Inc.
TABLE 101 Key Information – Merit Medical Systems, Inc.
TABLE 102 Key Information – HealthTronics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 SWOT Analysis: Boston Scientific Corporation
FIG 3 Swot analysis: Medtronic plc
FIG 4 SWOT analysis: Johnson & Johnson
FIG 5 Swot analysis: Becton, Dickinson and company